EMPOWER Breast Grand Rounds – Fullerton, CA
St. Jude Medical Center Cancer Data Management 2151 N. Harbor Dr., Fullerton, CA, United StatesThis live activity is focused on the care of patients with early HER2-positive breast cancer.
This live activity is focused on the care of patients with early HER2-positive breast cancer.
This initiative is designed to meet the educational needs of ER physicians and hematologist-oncologists involved in the treatment of patients with hemophilia.
This live activity is focused on the care of patients with early HER2-positive breast cancer.
This initiative is designed to meet the educational needs of ER physicians and hematologist-oncologists involved in the treatment of patients with hemophilia.
This live activity will cover the treatment and management of patients with metastatic colorectal cancer.
This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.
This activity is designed to meet the needs of US-based hematologists, medical oncologists, oncology nurses, and other healthcare providers involved in the treatment of AML and CLL.
This live activity will cover the treatment and management of patients with chronic lymphocytic leukemia.
This activity is designed to meet the needs of US-based hematologists, medical oncologists, oncology nurses, and other healthcare providers involved in the treatment of AML and CLL.
This live activity will cover the treatment and management of patients with metastatic colorectal cancer.
This live activity will cover the treatment and management of patients with metastatic colorectal cancer.
This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.